Replies to post #4934 on BioCryst Pharmaceuticals,Inc. (BCRX)

[agribusiness72]

Exactly, 8k is filed. 10K will have updates, 10Q will have revenues, 2nd 10Q will include Japans revenues, 3rd 10Q will have UK revenues, and all for Orladeyo. The factor D and galidesivir going to make this a hundred dollar stock by 2022/23. Exciting times ahead.